Brain-based visual prosthesis company’s new funding accelerates progress towards in-house manufacturing and first-in-human clinical trials, the first phase of which is scheduled Q3 2026.Belgian …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
